Hypoxia induced overexpression of PrPC in gastric cancer cell lines

Cancer Biology and Therapy

Volumn 6, Issue 5, 2007, Pages 769-774

  Liang, Jie ^a   Bai, Feihu ^a   Luo, Guanhong ^a   Wang, Jingbo ^a   Liu, Jingmei ^a   Ge, Fulin ^a   Pan, Yanglin ^a   Yao, Liping ^a   Du, Rui ^a   Li, Xiaohua ^a   Fan, Rui ^a   Zhang, Hongbo ^a   Guo, Xuegang ^a   Wu, Kaichun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ERK1 2; Gastric cancer cell; Hypoxia; PrPC

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PRION PROTEIN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG SENSITIVITY; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; STOMACH CANCER; UPREGULATION;

EID: 34548226398     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.5.4001     Document Type: Article

References (36)

1. Pammer J, Weninger W, Tschachler E. Human keratinocytes express cellular prion-related protein in vitro and during inflammatory skin diseases. Am J Pathol 1998; 153:1353-8.
2. Zhao Y, You H, Liu F, An H, Shi Y, Yu Q, Fan D. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002; 185:211-6.
3. Du J, Pan Y, Shi Y, Guo C, Jin X, Sun L, Liu N, Qiao T, Fan D. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int J Cancer 2005; 113:213-20.
4. C and its antiapoptosis function in gastric cancer. Tumour Biol 2006; 27:84-91.
5. Liang J, Ge FL, Lu YY, Wang J, Zhai HH, Yao LP, Li TT, Ji Q, Guo XY, Liu ZX, Fan D. Role of PrPc related to apoptosis. EXCLI Journal 2006; 5:11-24.
6. Pan Y, Zhao L, Liang J, Liu J, Shi Y, Liu N, Zhang G, Jin H, Gao J, Xie H, Wang J, Liu Z, Fan D. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J 2006; 20:1886-8.
7. Watt NT, Taylor DR, Gillott A, Thomas DA, Perera WS, Hooper NM. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J Biol Chem 2005; 280:35914-21.
8. McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, Ritchie D, Brannan F, Head MW, Ironside JW, Williams A, Bell JE. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 2004; 165:227-35.
9. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006; 441:437-43.
10. Boyle RG, Travers S. Hypoxia: Targeting the tumour. Anticancer Agents Med Chem 2006; 6:281-6.
11. Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM. Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer 2005; 41:2792-805.
12. Wang J, Wu K, Bai F, Zhai H, Xie H, Du Y, Liang J, Han S, Chen Y, Lin T, Fan D. Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer. Cancer Lett 2005, [in press].
13. Guo C, Ding J, Yao L, Sun L, Lin T, Song Y, Fan D. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by down regulating Bcl-2, MDR-1 and MPR-1. Int J Cancer 2005; 116:155-160.
14. C expression: Nerve growth factor (NGF) activates the prion gene promoter through the MEK1 pathway in PC12 cells. Neurosci Lett 2006; 400:58-62.
15. Woei-Cherng Shyu, Shinn-Zong Lin, Ming-Fu Chiang, Dah-Ching Ding, Kuo-Wei Li, Shih-Fen Chen, Hui-I Yang, Hung Li. Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. The Journal of Neuroscience 2005; 25:8967-77.
16. Xue Y, Bi F, Zhang X, Zhang S, Pan Y, Liu N, Shi Y, Yao X, Zheng Y, Fan D. Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation. Int J Cancer 2006; 118:2965-72.
17. Qiao TD, Liu CJ, Shi YQ, DU YL, Han S, Fan DM. A study on the regulatory mechanisms of mitogen-activated protein kinase phosphatase-1 in hypoxia inducible factor-1 trans-activation. Chines Med J 2005; 85:555-9.
18. Song MS, Park YK, Lee JH, Park K. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Cancer Res 2001; 61:8322-30.
19. Weise J, Sandau R, Schwarting S, Crome O, Wrede A, Schulz-Schaeffer W, Zerr I, Bahr M. Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 2006; 37:1296-300.
20. C signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells. J Biol Chem 2006, [in press].
21. Liu L, Simon MC. Regulation of transcription and translation by hypoxia. Cancer Biol Ther 2004; 3:492-7.
22. C by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 2005; 25:8967-77.
23. Sauer H, Dagdanova A, Hescheler J, Wartenberg M. Redox-regulation of intrinsic prion expression in multicellular prostate tumor spheroids. Free Radic Biol Med 1999; 27:1276-83.
24. Brown DR, Schmidt B, Kretzschmar HA. Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem 1998; 70:1686-93.
25. White AR, Collins SJ, Maher F, Jobling MF, Stewart LR, Thyer JM, Beyreuther K, Masters CL, Cappai R. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 1999; 155:23-1730.
26. Brown DR, Nicholas RSJ, Canevari L. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 2002; 67:211-24.
27. Klamt F, Dal-Pizzol F, Conte da Frota MLJR, Walz R, Andrades ME, daSilva EG, Brentani RR, Izquierdo I, Fonseca Moreira JC. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med 2001; 30:1137-44.
28. Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, Gambetti P, Perry G, Manson JC, Brown DR, Sy MS. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 2001; 76:565-72.
29. Sakudo A, Lee DC, Nishimura T, Li S, Tsuji S, Nakamura T, Matsumoto Y, Saeki K, Itohara S, Ikuta K, Onodera T. Octapeptide repeat region and N-terminal half of hydrophobic region of prion protein (PrP) mediate PrP-dependent activation of superoxide dismutase. Biochem Biophys Res Commun 2005; 326:600-6.
30. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: The paradox of increased ROS during hypoxia. Exp Physiol 2006, [in press].
31. Crozet C, Vezilier J, Delfieu V, Nishimura T, Onodera T, Casanova D, Lehmann S, Beranger F. The truncated 23-230 form of the prion protein localizes to the nuclei of inducible cell lines independently of its nuclear localization signals and is not cytotoxic. Mol Cell Neurosci 2006; 32:315-23.
32. Lima LM, Cordeiro Y, Tinoco LW, Marques AF, Oliveira CL, Sampath S, Kodali R, Choi G, Foguel D, Torriani I, Caughey B, Silva JL. Structural insights into the interaction between prion protein and nucleic acid. Biochemistry 2006; 45:9180-7.
33. Zhang Q, Wang SY, Nottke AC, Rocheleau JV, Piston DW, Goodman RH. Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci USA 2006; 103:9029-33.
34. Wang GL, Jiang BH, Semenza GL. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem Biophys Res Commun 1995; 216:669-75.
35. SekoY, Takahashi N, Tobe K, Kadowaki T, Yazaki Y. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 1997; 239:840-844.
36. Wartenberg M, Gronczynska S, Bekhite MM, Saric T, Niedermeier W, Hescheler J, Sauer H. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species. Int J Cancer 2005; 113:229-40.